Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins
about
Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules.Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationAbsence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.EpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.Regulation of Immunogen Processing: Signal Sequences and Their Application for the New Generation of DNA-VaccinesIdentification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.Protective and destructive immunity in the periodontium: Part 2--T-cell-mediated immunity in the periodontium.Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP.Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.Efficient Presentation of Multiple Endogenous Epitopes to Both CD4+ and CD8+ Diabetogenic T Cells for ToleranceA novel family of human leukocyte antigen class II receptors may have its origin in archaic human speciesInhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51.Recombinant poxviruses: versatile tools for immunological assays.Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.Multi-epitope DNA vaccines.DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.Endosomal compartment: Also a dock for MHC class I peptide loading.Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.Ectopic Expression of Self-Antigen Drives Regulatory T Cell Development and Not Deletion of Autoimmune T Cells.Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8 T Cell Responses
P2860
Q30884856-F1F29E4A-849A-4DF1-9EEC-7AF4740212BDQ33779750-3D806967-6D14-46F0-8DE4-8A3ADA613F7DQ33782440-625D1246-7204-40CB-AEAE-4233C049CC40Q33820413-3D74F675-54C5-4CDF-8DB2-6DC0DC1D21C0Q33831207-2D009C82-809E-4FF8-95B8-C562E498C83AQ33947082-9BDE4784-AE58-4FCE-9B65-3FA02F092DF4Q34121306-C2D7396C-A95A-454C-8880-A30FC52586B7Q34482074-3B1A29B4-1BE5-4003-8EAF-06C62BE41A3EQ34968934-B5B0A0D6-C50E-46A3-B1EF-18FCFE4CD27DQ35241354-22CAABC4-701A-4530-A4D1-14D7EEE7889EQ35791686-A430353F-3D25-4599-9833-457E55C129B7Q35944304-FC4F43D1-ADAB-4563-97EE-88FDA0325042Q36367841-3D77D773-7E39-4AB2-B39A-7904B3E92732Q36369960-3AB4A09E-A9E3-454A-8D25-389855F64F36Q36404753-91A89A27-5D35-415D-AA3D-F5280686E64EQ36659166-62488B49-17E9-4E9F-A9F6-4BE9B060554BQ37389304-1BEF47E2-AB96-4E3F-8FA7-432010B0465EQ37717905-B503DE65-1A0D-490C-A1C4-8AE16353E06DQ39064744-32428F1F-BEBD-457E-BD11-0031100CAF44Q39093643-0548F948-6227-4D31-8124-4B1ED8CFB4EBQ39208693-9AFB8F3D-6FE3-4737-B24A-74A5AFAF902AQ40809420-4A8341C5-4B9F-44F2-8E11-FE5FCF63E3DDQ41604754-224162D0-A3BA-45CB-A3B9-7C84B68A8CC4Q41917453-FD2AE331-E0CC-47FE-B364-E0257D1EE8A4Q41926475-EE2A0EB1-C7D7-4CFD-A317-A4212BC0E191Q42237834-C30295DE-0980-402C-B019-40EBB75DD602Q44991675-65F18508-37F5-483A-897D-19CE79F5E9B9Q45739949-B327B70E-629B-4B0B-9BB8-26C6CF301BE7Q45876566-49AF7F52-44B5-4BF4-9754-48355B69CAABQ48186081-0A6C6A9F-CF8F-4FC5-8AE4-3A6981BBD000Q54508395-B3B9B48C-AAA6-446A-A6A1-16BE5FF2DC7FQ57292428-3F03C78F-9C58-4AE6-BFA8-AC0249E74C0C
P2860
Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Expression of endogenous pepti ...... chain-antigen fusion proteins
@ast
Expression of endogenous pepti ...... chain-antigen fusion proteins
@en
Expression of endogenous pepti ...... chain-antigen fusion proteins
@nl
type
label
Expression of endogenous pepti ...... chain-antigen fusion proteins
@ast
Expression of endogenous pepti ...... chain-antigen fusion proteins
@en
Expression of endogenous pepti ...... chain-antigen fusion proteins
@nl
prefLabel
Expression of endogenous pepti ...... chain-antigen fusion proteins
@ast
Expression of endogenous pepti ...... chain-antigen fusion proteins
@en
Expression of endogenous pepti ...... chain-antigen fusion proteins
@nl
P2093
P2860
P356
P1476
Expression of endogenous pepti ...... chain-antigen fusion proteins
@en
P2093
Frauwirth K
Sanderson S
P2860
P304
P356
10.1073/PNAS.92.16.7217
P407
P577
1995-08-01T00:00:00Z